4
Changes in Ownership
Cellectar Biosciences, Inc. Filed Acc 0001104659-20-139783
Chief Financial Officer bought 7,407 shares at $1.35 ($9,999)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Elefant Dov Chief Financial Officer | 2020-12-28 | Purchase | +7,407 | $1.35 | $9,999 | 11,755 | D |
| Open-market purchases · 7,407 sh · avg $1.35 · $9,999 | |||||||
Loading xslF345X03/tm2039438d1_4.xml…